학술논문
Impact of omalizumab on patient-reported outcomes in chronic idiopathic urticaria: Results from a randomized study (XTEND-CIU)
Document Type
Short Communication
Author
Source
In The Journal of Allergy and Clinical Immunology: In Practice September-October 2019 7(7):2487-2490
Subject
Language
ISSN
2213-2198